Download PDF
Radiopraxis 2020; 13(01): E14-E31
DOI: 10.1055/a-1096-6467
CPD–Fortbildung

Lokal ablative Therapie bei Lebertumoren

Frank Fischbach
,
Jens Ricke
,
Katharina Fischbach
› Further Information
Also available at
    Permissions and Reprints

In den letzten Jahren stehen bei Patienten mit Lebertumoren interdisziplinäre Therapieansätze mit Betonung minimalinvasiver Verfahren zur Reduktion der Tumorlast zunehmend im Fokus. Lokal ablative Verfahren zur Behandlung des HCC und von Lebermetastasen kolorektaler Tumoren sind bereits in Behandlungsempfehlungen und Leitlinien integriert. Der folgende Beitrag stellt die häufigsten Verfahren vor und beschreibt ihre Relevanz für den klinischen Alltag.



Publication History

Article published online:
05 March 2020

© Georg Thieme Verlag KG
Stuttgart · New York

 

  • Literatur

  • 1 Van Cutsem E, Cervantes A, Adam R. et al. , ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 2016; 27: 1386-1422
    CrossrefPubMedGoogle Scholar
  • 2 Rhim H, Goldberg SN, Dodd GD. 3rd et al. Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors. Radiographics. 2001 21(Spec No): S17-35; discussion S36-S39
    PubMedGoogle Scholar
  • 3 Pereira PL, Trubenbach J, Schmidt D. Radiofrequency ablation: basic principles, techniques and challenges. Rofo 2003; 175: 20-27
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Elias D, Baton O, Sideris L. , et al. Local recurrences after intraoperative radiofrequency ablation of liver metastases: a comparative study with anatomic and wedge resections. Ann Surg Oncol 2004; 11: 500-505
    CrossrefPubMedGoogle Scholar
  • 5 Bruners P, Schmitz-Rode T, Gunther RW. , et al. Multipolar hepatic radiofrequency ablation using up to six applicators: preliminary results. Rofo 2008; 180: 216-222
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics 2005; 25 (Suppl 1): S69-S83
    CrossrefPubMedGoogle Scholar
  • 7 Hoffmann R, Rempp H, Erhard L. , et al. Comparison of four microwave ablation devices: an experimental study in ex vivo bovine liver. Radiology 2013; 268: 89-97
    CrossrefPubMedGoogle Scholar
  • 8 Carrafiello G, Lagana D, Mangini M. , et al. Microwave tumors ablation: principles, clinical applications and review of preliminary experiences. Int J Surg 2008; 6 (Suppl 1): S65-S69
    CrossrefPubMedGoogle Scholar
  • 9 Brace CL. Microwave ablation technology: what every user should know. Curr Probl Diagn Radiol 2009; 38: 61-67
    CrossrefPubMedGoogle Scholar
  • 10 Pech M, Werk M, Beck A. , et al. System continuity and energy distribution in laser-induced thermo therapy (LITT). Rofo 2002; 174: 754-760
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998; 37: 171-186
    CrossrefPubMedGoogle Scholar
  • 12 Niu LZ, Li JL, Xu KC. Percutaneous Cryoablation for Liver Cancer. J Clin Transl Hepatol 2014; 2: 182-188
    PubMedGoogle Scholar
  • 13 Allen BC, Remer EM. Percutaneous cryoablation of renal tumors: patient selection, technique, and postprocedural imaging. Radiographics 2010; 30: 887-900
    CrossrefPubMedGoogle Scholar
  • 14 Junginger T, Seifert JK, Weigel TF. , et al. Cryotherapy of liver metastases. Initial results. Med Klin (Munich) 1998; 93: 517-523
    PubMedGoogle Scholar
  • 15 Hinshaw JL, Lubner MG, Ziemlewicz TJ. , et al. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation – what should you use and why?. Radiographics 2014; 34: 1344-1362
    CrossrefPubMedGoogle Scholar
  • 16 Bretschneider T, Peters N, Hass P. , et al. Update on interstitial brachytherapy. Radiologe 2012; 52: 70-73
    CrossrefPubMedGoogle Scholar
  • 17 Ricke J, Wust P, Stohlmann A. , et al. CT-Guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver metastases. Strahlenther Onkol 2004; 180: 274-280
    PubMedGoogle Scholar
  • 18 Narayanan G. Irreversible Electroporation. Semin Intervent Radiol 2015; 32: 349-355
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Dollinger M, Zeman F, Niessen C. , et al. Bile duct injury after irreversible electroporation of hepatic malignancies: evaluation of MR imaging findings and laboratory values. J Vasc Interv Radiol 2016; 27: 96-103
    CrossrefPubMedGoogle Scholar
  • 20 Kasper HU, Drebber U, Dries V. , et al. Liver metastases: incidence and histogenesis. Z Gastroenterol 2005; 43: 1149-1157
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Kanas GP, Taylor A, Primrose JN. , et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 2012; 4: 283-301
    Google Scholar
  • 22 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA: a cancer journal for clinicians 2015; 65: 5-29
    CrossrefPubMedGoogle Scholar
  • 23 Gillams AR, Lees WR. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 2009; 19: 1206-1213
    CrossrefPubMedGoogle Scholar
  • 24 Grundmann RT, Hermanek P, Merkel S. , et al. Diagnosis and treatment of colorectal liver metastases – workflow. Zentralbl Chir 2008; 133: 267-284
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Berber E, Pelley R, Siperstein AE. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 2005; 23: 1358-1364
    CrossrefPubMedGoogle Scholar
  • 26 Stang A, Fischbach R, Teichmann W. , et al. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer 2009; 45: 1748-1756
    CrossrefPubMedGoogle Scholar
  • 27 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, AWMF):. S3-Leitlinie Kolorektales Karzinom, Version 2014. Im Internet:. http://Leitlinienprogramm-Onkologie.De/Leitlinien.7.0.html ; Stand: 15.05.2017
    Google Scholar
  • 28 Fong Y, Fortner J, Sun RL. , et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318 ; discussion 318-321
    CrossrefPubMedGoogle Scholar
  • 29 Mahnken AH, Bruners P, Tacke JA. , et al. CT-guided radiofrequency ablation of liver metastases from colorectal cancer. Dtsch Med Wochenschr 2009; 134: 976-980
    Article in Thieme ConnectPubMedGoogle Scholar
  • 30 Lordick F, Knodler M, Hacker U. , et al. Neoadjuvant chemotherapy or primary surgery for colorectal liver metastases. Pro adjuvant chemotherapy. Chirurg 2014; 85: 11-16
    CrossrefPubMedGoogle Scholar
  • 31 Settmacher U, Scheuerlein H, Rauchfuss F. Assessment of resectability of colorectal liver metastases and extended resection. Chirurg 2014; 85: 24-30
    CrossrefPubMedGoogle Scholar
  • 32 Mantke R, Niepmann D, Gastinger I. , et al. Hepatic resections. Analysis of data from the Tumor Documentation Center in the state of Brandenburg, Germany, focusing on liver metastases of colorectal carcinoma. Chirurg 2006; 77: 1135-1143
    CrossrefPubMedGoogle Scholar
  • 33 Mulier S, Ni Y, Jamart J. , et al. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial?. Ann Surg Oncol 2008; 15: 144-157
    CrossrefPubMedGoogle Scholar
  • 34 Tanis E, Nordlinger B, Mauer M. , et al. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983. Eur J Cancer 2014; 50: 912-919
    Google Scholar
  • 35 Vigano L, Capussotti L, Lapointe R. , et al. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncol 2014; 21: 1276-1286
    CrossrefPubMedGoogle Scholar
  • 36 Welsh FK, Tekkis PP, Oʼrourke T. et al. Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: an aid to clinical decision-making. Surg Oncol 2008; 17: 3-13
    CrossrefPubMedGoogle Scholar
  • 37 Smith MD, Mccall JL. Systematic review of tumour number and outcome after radical treatment of colorectal livermetastases. Br J Surg 2009; 96: 1101-1113
    CrossrefPubMedGoogle Scholar
  • 38 Livraghi T, Solbiati L, Meloni MF. , et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226: 441-451
    CrossrefPubMedGoogle Scholar
  • 39 Mahnken AH, Pereira PL, De Baere T. Interventional oncologic approaches to liver metastases. Radiology 2013; 266: 407-430
    CrossrefPubMedGoogle Scholar
  • 40 Ruers T, Punt C, Van Coevorden F. , et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC40004). Ann Oncol 2012; 23: 2619-2626
    CrossrefPubMedGoogle Scholar
  • 41 Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995; 13: 8-10
    CrossrefPubMedGoogle Scholar
  • 42 Milano MT, Katz AW, Zhang H. , et al. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys 2012; 83: 878-886
    CrossrefPubMedGoogle Scholar
  • 43 Evrard S, Poston G, Kissmeyer-Nielsen P. , et al. Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases. PLoS One 2014; 9: e114404
    CrossrefPubMedGoogle Scholar
  • 44 Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010; 51: 1820-1832
    CrossrefPubMedGoogle Scholar
  • 45 European Association for the Study of The L, European Organisation For R, Treatment Of C. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-943
    CrossrefPubMedGoogle Scholar
  • 46 Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Seminars in liver disease 2005; 25: 181-200
    Article in Thieme ConnectPubMedGoogle Scholar
  • 47 Liu PH, Hsu CY, Hsia CY. , et al. Surgical resection versus radiofrequency ablation for single hepatocellular carcinoma ≤ 2 cm in a propensity score model. Ann Surg 2016; 263: 538-545
    CrossrefPubMedGoogle Scholar
  • 48 Jaskolka JD, Asch MR, Kachura JR. , et al. Needle tract seeding after radiofrequency ablation of hepatic tumors. J Vasc Interv Radiol 2005; 16: 485-491
    CrossrefPubMedGoogle Scholar
  • 49 Yamakado K, Nakatsuka A, Takaki H. , et al. Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 2008; 247: 260-266
    CrossrefPubMedGoogle Scholar
  • 50 Park EK, Kim HJ, Kim CY. , et al. A comparison between surgical resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. Ann Surg Treat Res 2014; 87: 72-80
    CrossrefPubMedGoogle Scholar
  • 51 Verslype C, Rosmorduc O, Rougier P. , et al. Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23 (Suppl 7): vii 41-48
    Google Scholar
  • 52 Lee DH, Lee JM, Lee JY. , et al. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Radiology 2014; 270: 900-909
    CrossrefPubMedGoogle Scholar
  • 53 Wang Y, Luo Q, Li Y. , et al. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a metaanalysis of randomized and nonrandomized controlled trials. PLoS One 2014; 9: e84484
    CrossrefPubMedGoogle Scholar
  • 54 Lencioni RA, Allgaier HP, Cioni D. , et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-240
    CrossrefPubMedGoogle Scholar
  • 55 Streitparth F, Pech M, Bohmig M. , et al. In vivo assessment of the gastric mucosal tolerance dose after single fraction, small volume irradiation of liver malignancies by computed tomography-guided, high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2006; 65: 1479-1486
    CrossrefPubMedGoogle Scholar
  • 56 Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174: 323-331
    CrossrefPubMedGoogle Scholar
  • 57 Park MH, Rhim H, Kim YS. , et al. Spectrum of CT findings after radiofrequency ablation of hepatic tumors. Radiographics 2008; 28: 379-390 ; discussion 390-392
    CrossrefPubMedGoogle Scholar
  • 58 Mitsuzaki K, Yamashita Y, Nishiharu T. , et al. CT appearance of hepatic tumors after microwave coagulation therapy. AJR Am J Roentgenol 1998; 171: 1397-1403
    CrossrefPubMedGoogle Scholar
  • 59 Kim SK, Lim HK, Kim YH. , et al. Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings. Radiographics 2003; 23: 107-121
    CrossrefPubMedGoogle Scholar
  • 60 Onishi H, Matsushita M, Murakami T. , et al. MR appearances of radiofrequency thermal ablation region: histopathologic correlation with dog liver models and an autopsy case. Acad Radiol 2004; 11: 1180-1189
    CrossrefPubMedGoogle Scholar
  • 61 Fischbach F, Bunke J, Thormann M. , et al. MR-guided freehand biopsy of liver lesions with fast continuous imaging using a 1.0-T open MRI scanner: experience in 50 patients. Cardiovasc Intervent Radiol 2011; 34: 188-192
    CrossrefPubMedGoogle Scholar
  • 62 Clasen S, Pereira PL. Magnetic resonance guidance for radiofrequency ablation of liver tumors. J Magn Reson Imaging 2008; 27: 421-433
    CrossrefPubMedGoogle Scholar
  • 63 Mueller-Lisse UG, Thoma M, Faber S. , et al. Coagulative interstitial laser-induced thermotherapy of benign prostatic hyperplasia: online imaging with a T2-weighted fast spin-echo MR sequence-experience in six patients. Radiology 1999; 210: 373-379
    CrossrefPubMedGoogle Scholar
  • 64 Rempp H, Clasen S, Pereira PL. Image-based monitoring of magnetic resonance-guided thermoablative therapies for liver tumors. Cardiovasc Intervent Radiol 2012; 35: 1281-1294
    CrossrefPubMedGoogle Scholar
  • 65 Stoffner R, Schullian P, Widmann G. , et al. Magnetic resonance imaging of radiofrequency current-induced coagulation zones in the ex vivo bovine liver. Rofo 2010; 182: 690-697
    Article in Thieme ConnectPubMedGoogle Scholar
  • 66 Fischbach F, Lohfink K, Gaffke G. , et al. Magnetic resonanceguided freehand radiofrequency ablation of malignant liver lesions: a new simplified and time-efficient approach using an interactive open magnetic resonance scan platform and hepatocyte-specific contrast agent. Invest Radiol 2013; 48: 422-428
    CrossrefPubMedGoogle Scholar
  • 67 Kuszyk BS, Choti MA, Urban BA. , et al. Hepatic tumors treated by cryosurgery: normal CT appearance. AJR Am J Roentgenol 1996; 166: 363-368
    CrossrefPubMedGoogle Scholar
  • 68 Shyn PB, Oliva MR, Shah SH. , et al. MRI contrast enhancement of malignant liver tumours following successful cryoablation. Eur Radiol 2012; 22: 398-403
    CrossrefPubMedGoogle Scholar
  • 69 Dodd GD. , 3rd, Frank MS, Aribandi M et al. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol 2001; 177: 777-782
    CrossrefPubMedGoogle Scholar
  • 70 Antoch G, Kuehl H, Vogt FM. , et al. Value of CT volume imaging for optimal placement of radiofrequency ablation probes in liver lesions. J Vasc Interv Radiol 2002; 13: 1155-1161
    CrossrefPubMedGoogle Scholar
  • 71 Poon RT, Ng KK, Lam CM. , et al. Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg 2004; 239: 441-449
    CrossrefPubMedGoogle Scholar
  • 72 Lu DS, Raman SS, Limanond P. , et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 2003; 14: 1267-1274
    CrossrefPubMedGoogle Scholar
  • 73 Livraghi T, Lazzaroni S, Meloni F. , et al. Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2005; 92: 856-858
    CrossrefPubMedGoogle Scholar
  • 74 Collettini F, Lutter A, Schnapauff D. , et al. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT). Rofo 2014; 186: 606-612
    Article in Thieme ConnectPubMedGoogle Scholar
  • 75 Ricke J, Thormann M, Ludewig M. , et al. MR-guided liver tumor ablation employing open high-field 1.0 T MRI for imageguided brachytherapy. Eur Radiol 2010; 20: 1985-1993
    CrossrefPubMedGoogle Scholar
  • 76 Mohnike K, Sauerland H, Seidensticker M. , et al. Haemorrhagic complications and symptomatic venous thromboembolism in interventional tumour ablations: the impact of peri-interventional thrombosis prophylaxis. Cardiovasc Intervent Radiol 2016; 39: 1716-1721
    CrossrefPubMedGoogle Scholar
  • 77 Ohmoto K, Tsuduki M, Kunieda T. , et al. CT appearance of hepatic parenchymal changes after percutaneous microwave coagulation therapy for hepatocellular carcinoma. J Comput Assist Tomogr 2000; 24: 866-871
    CrossrefPubMedGoogle Scholar
  • 78 Carrafiello G, Lagana D, Ianniello A. , et al. Post-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumours: one centre experience and review of published works. Australas Radiol 2007; 51: 550-554
    CrossrefPubMedGoogle Scholar